Intestinal Research

Statements

IBD

Management of Crohn’s disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023: Jia-Feng Wu, Hsu-Heng Yen, Horng-Yuan Wang, Ting-An Chang, Chung-Hsin Chang, Chen-Wang Chang, Te-Hsin Chao, Jen-Wei Chou, Yenn-Hwei Chou, Chiao-Hsiung Chuang, Wen-Hung Hsu, Tzu-Chi Hsu, Tien-Yu Huang, Tsung-I Hung, Puo-Hsien Le, Chun-Che Lin, Chun-Chi Lin, Ching-Pin Lin, Jen-Kou Lin, Wei-Chen Lin, Yen-Hsuan Ni, Ming-Jium Shieh, I-Lun Shih, Chia-Tung Shun, Tzung-Jiun Tsai, Cheng-Yi Wang, Meng-Tzu Weng, Jau-Min Wong, Deng-Chyang Wu, Shu-Chen Wei; Intest Res 2024;22(3):250-285. Published online July 29, 2024; DOI: https://doi.org/10.5217/ir.2024.00060

Abstract PDF PubReader ePub: Crohn’s disease (CD) is a chronic, fluctuating inflammatory condition that primarily affects the gastrointestinal tract. Although the incidence of CD in Taiwan is lower than that in Western countries, the severity of CD presentation appears to be similar between Asia and the West. This observation indicates the urgency for devising revised guidelines tailored to the unique reimbursement system, and patient requirements in Taiwan. The core objectives of these updated guidelines include the updated treatment choices and the integration of the treat-to-target strategy into CD management, promoting the achievement of deep remission to mitigate complications and enhance the overall quality of life. Given the diversity in disease prevalence, severity, insurance policies, and access to medical treatments in Taiwan, a customized approach is imperative for formulating these guidelines. Such tailored strategies ensure that international standards are not only adapted but also optimized to local contexts. Since the inception of its initial guidelines in 2017, the Taiwan Society of Inflammatory Bowel Disease (TSIBD) has acknowledged the importance of continuous revisions for incorporating new therapeutic options and evolving disease management practices. The latest update leverages international standards and recent research findings focused on practical implementation within the Taiwanese healthcare system.

4,163 View
207 Download

IBD

Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023: Hsu-Heng Yen, Jia-Feng Wu, Horng-Yuan Wang, Ting-An Chang, Chung-Hsin Chang, Chen-Wang Chang, Te-Hsin Chao, Jen-Wei Chou, Yenn-Hwei Chou, Chiao-Hsiung Chuang, Wen-Hung Hsu, Tzu-Chi Hsu, Tien-Yu Huang, Tsung-I Hung, Puo-Hsien Le, Chun-Che Lin, Chun-Chi Lin, Ching-Pin Lin, Jen-Kou Lin, Wei-Chen Lin, Yen-Hsuan Ni, Ming-Jium Shieh, I-Lun Shih, Chia-Tung Shun, Tzung-Jiun Tsai, Cheng-Yi Wang, Meng-Tzu Weng, Jau-Min Wong, Deng-Chyang Wu, Shu-Chen Wei; Intest Res 2024;22(3):213-249. Published online July 29, 2024; DOI: https://doi.org/10.5217/ir.2023.00050

Abstract PDF PubReader ePub

Ulcerative colitis (UC) is a chronic inflammation of the gastrointestinal tract and is characterized by alternating periods of inflammation and remission. Although UC incidence is lower in Taiwan than in Western countries, its impact remains considerable, demanding updated guidelines for addressing local healthcare challenges and patient needs. The revised guidelines employ international standards and recent research, emphasizing practical implementation within the Taiwanese healthcare system. Since the inception of the guidelines in 2017, the Taiwan Society of Inflammatory Bowel Disease has acknowledged the need for ongoing revisions to incorporate emerging therapeutic options and evolving disease management practices. This updated guideline aims to align UC management with local contexts, ensuring comprehensive and context-specific recommendations, thereby raising the standard of care for UC patients in Taiwan. By adapting and optimizing international protocols for local relevance, these efforts seek to enhance health outcomes for patients with UC.

Citations

Citations to this article as recorded by

Short-term and long-term outcomes of acute severe ulcerative colitis in Taiwan: a multicenter study with pre- and post-biologics comparison
Wei-Chen Lin, Chun-Chi Lin, Wen-Hung Hsu, Feng-Fan Chiang, Chen-Wang Chang, Tzu-Chi Hsu, Deng-Chyang Wu, Horng-Yuan Wang, Jau-Min Wong, Shu-Chen Wei
Intestinal Research.2025;[Epub] CrossRef
Endoscopic Techniques for Colorectal Neoplasia Surveillance in Inflammatory Bowel Disease: A Systematic Review and Network Meta‐Analysis
Chih‐Wen Huang, Hsu‐Heng Yen, Yang‐Yuan Chen
United European Gastroenterology Journal.2025;[Epub] CrossRef
Rescue Therapies for Steroid-refractory Acute Severe Ulcerative Colitis: A Systematic Review and Network Meta-analysis
Chih-Wen Huang, Hsu-Heng Yen, Yang-Yuan Chen
Journal of Crohn's and Colitis.2024; 18(12): 2063. CrossRef
High prevalence of vitamin D deficiency in Taiwanese patients with inflammatory bowel disease
Chen-Ta Yang, Hsu-Heng Yen, Pei-Yuan Su, Yang-Yuan Chen, Siou-Ping Huang
Scientific Reports.2024;[Epub] CrossRef

5,378 View
252 Download
4 Crossref

Original Article

IBD

Association of young age and male sex with primary sclerosing cholangitis in Taiwanese patients with inflammatory bowel disease: Meng-Tzu Weng, I-Lun Shih, Chien-Chih Tung, Yew-Loong Leong, Ming-Jium Shieh, Cheng-Yi Wang, Jau-Min Wong, Yen-Hsuan Ni, Shu-Chen Wei; Intest Res 2022;20(2):224-230. Published online February 8, 2022; DOI: https://doi.org/10.5217/ir.2021.00042

Abstract PDF Supplementary Material PubReader ePub

Background/Aims
Primary sclerosing cholangitis (PSC) is associated with inflammatory bowel disease (IBD). We aimed to evaluate the prevalence, clinical manifestation, and outcomes of PSC in Taiwanese patients with IBD. Methods: This retrospective study enrolled patients with IBD admitted from January 1, 1996, to December 31, 2018, to National Taiwan University Hospital. A case-matched analysis was performed comparing patients with IBD with and without PSC according to age, sex, and time of admission, with ratios of 1:4 and 1:2 in the adult and pediatric groups, respectively.
Results
In total, 763 patients with IBD were enrolled, 12 of whom were also diagnosed with PSC (1.57%). All these patients had ulcerative colitis (UC). A greater incidence of IBD with PSC was observed in younger patients than in older patients. Male sex was a risk factor for PSC in pediatric patients with IBD (P=0.015); 75% of these patients were diagnosed with PSC along with or after the diagnosis of UC. There was no significant difference in colitis extent and severity between the groups; however, a higher proportion of rectal sparing was observed in patients with PSC (P=0.001). There was no significant difference in cancer development between the groups (P=0.679). Conclusions: A 1.57% prevalence of PSC was observed in Taiwanese patients with IBD. The majority of patients with IBD and PSC were men and were diagnosed at a younger age. Hence, routine evaluation of biliary enzymes and liver imaging is recommended in young male patients with IBD.

Citations

Citations to this article as recorded by

Hepatic Steatosis but Not Fibrosis Is Independently Associated with Poor Outcomes in Patients with Inflammatory Bowel Disease
Hye Kyung Hyun, Hye Won Lee, Jihye Park, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jae Seung Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim, Jae Hee Cheon
Gut and Liver.2024; 18(2): 294. CrossRef
Safety of Biologics and Small Molecules for Inflammatory Bowel Diseases in Organ Transplant Recipients
Ga Hee Kim, Minjun Kim, Kyuwon Kim, Jung-Bin Park, Ji Eun Baek, June Hwa Bae, Seung Wook Hong, Sung Wook Hwang, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Sang Hyoung Park
Yonsei Medical Journal.2024; 65(5): 276. CrossRef
Incidence and adverse clinical events of primary sclerosing cholangitis with ulcerative colitis
In Sub Han, Dong Hoon Baek, Seung Min Hong, Bong Eun Lee, Moon Won Lee, Gwang Ha Kim, Geun Am Song
International Journal of Colorectal Disease.2023;[Epub] CrossRef
Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut–liver axis
You Sun Kim, Edward H. Hurley, Yoojeong Park, Sungjin Ko
Experimental & Molecular Medicine.2023; 55(7): 1380. CrossRef
Treatment of primary sclerosing cholangitis combined with inflammatory bowel disease
You Sun Kim, Edward H. Hurley, Yoojeong Park, Sungjin Ko
Intestinal Research.2023; 21(4): 420. CrossRef
Regional variations in the prevalence of primary sclerosing cholangitis associated with inflammatory bowel disease
Kwang Woo Kim, Hyoun Woo Kang
Intestinal Research.2023; 21(4): 413. CrossRef
Is primary sclerosing cholangitis with inflammatory bowel disease different between patients in the East and West?
Yong Eun Park
Intestinal Research.2022; 20(2): 157. CrossRef

4,476 View
266 Download
8 Web of Science
7 Crossref

Reviews

Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease: Shu-Chen Wei, Ting-An Chang, Te-Hsin Chao, Jinn-Shiun Chen, Jen-Wei Chou, Yenn-Hwei Chou, Chiao-Hsiung Chuang, Wen-Hung Hsu, Tien-Yu Huang, Tzu-Chi Hsu, Chun-Chi Lin, Hung-Hsin Lin, Jen-Kou Lin, Wei-Chen Lin, Yen-Hsuan Ni, Ming-Jium Shieh, I-Lun Shih, Chia-Tung Shun, Yuk-Ming Tsang, Cheng-Yi Wang, Horng-Yuan Wang, Meng-Tzu Weng, Deng-Chyang Wu, Wen-Chieh Wu, Hsu-Heng Yen, Jau-Min Wong; Intest Res 2017;15(3):285-310. Published online June 12, 2017; DOI: https://doi.org/10.5217/ir.2017.15.3.285

Abstract PDF PubReader ePub

Crohn's disease (CD) is a chronic relapsing and remitting inflammatory disease of the gastrointestinal tract. CD is rare in Taiwan and other Asian countries, but its prevalence and incidence have been steadily increasing. A steering committee was established by the Taiwan Society of Inflammatory Bowel Disease to formulate statements on the diagnosis and management of CD taking into account currently available evidence and the expert opinion of the committee. Thorough clinical, endoscopic, and histological assessments are required for accurate diagnosis of CD. Computed tomography and magnetic resonance imaging are complementary to endoscopic evaluation for disease staging and detecting complications. The goals of CD management are to induce and maintain remission, reduce the risk of complications, and improve quality of life. Corticosteroids are the mainstay for inducing re-mission. Immunomodulating and biologic therapies should be used to maintain remission. Patients should be evaluated for hepatitis B virus and tuberculosis infection prior to treatment and receive regular surveillance for cancer. These consensus statements are based on current local evidence with consideration of factors, and could be serve as concise and practical guidelines for supporting clinicians in the management of patients with CD in Taiwan.

Citations

Citations to this article as recorded by

Factors affecting perception and acceptance of colonoscopy in patients with inflammatory bowel disease
Chang-Hung Liao, Peng-Jen Chen, Yu-Lueng Shih, Wei-Kuo Chang, Tsai-Yuan Hsieh, Tien-Yu Huang
Preventive Medicine Reports.2025; 49: 102951. CrossRef
Management of Crohn’s disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023
Jia-Feng Wu, Hsu-Heng Yen, Horng-Yuan Wang, Ting-An Chang, Chung-Hsin Chang, Chen-Wang Chang, Te-Hsin Chao, Jen-Wei Chou, Yenn-Hwei Chou, Chiao-Hsiung Chuang, Wen-Hung Hsu, Tzu-Chi Hsu, Tien-Yu Huang, Tsung-I Hung, Puo-Hsien Le, Chun-Che Lin, Chun-Chi Lin
Intestinal Research.2024; 22(3): 250. CrossRef
Current State of CT Enterography in Diagnostics and Surgical Tactics in Crohn’s Disease (Literature Review)
A. L. Aprosimov, D. A. Lezhnev, Yu. V. Kulezneva
Radiology - Practice.2024; (6): 67. CrossRef
Suboptimal Outcomes and Retreatment Rate of Patients With Crohn's Disease After Forced Discontinuation of Biologics: A Nationwide Population‐Based Study
Nai‐Yu Chen, Chiao‐Hsiung Chuang, Yu‐Ching Chang, Yea‐Huei Kao Yang, Peng‐Hsu Chen, Ching‐Lan Cheng
Clinical Pharmacology & Therapeutics.2023; 114(4): 914. CrossRef
Health Maintenance and Preventative Care in Inflammatory Bowel Disease
Simcha Weissman, Hannah K. Systrom, Ayrton Bangolo, Daniel Elias, Marcel Awasi, Tamer Zahdeh, Chukwuemeka E. Ogbu, Mishka Hoo Kim, Meenal Kalra, Kavya Khota, Ritu B. Kasarapu, Erasmus Mutabi, Moinulhaq Makrani, Sanskrita Nemalikanti, Jim Thomas, Joseph P.
Journal of Clinical Gastroenterology.2023; 57(4): 325. CrossRef
Negative pressure wound management in perineal wound status post abdominoperineal resection and extralevator abdominoperineal excision: a meta-analysis and trial sequential analysis
Cheng-Wei Fan, Po-Huang Chen, Hong-Jie Jhou, Yi-Chiao Cheng
International Journal of Colorectal Disease.2023;[Epub] CrossRef
Treatment of inflammatory bowel disease–Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
Eun Mi Song, Soo-Young Na, Sung Noh Hong, Siew Chien Ng, Tadakazu Hisamatsu, Byong Duk Ye
Intestinal Research.2023; 21(3): 339. CrossRef
IBD barriers across the continents – East Asia
Joyce Wing Yan Mak, Agnes Hiu Yan Ho, Siew Chien Ng
Therapeutic Advances in Gastroenterology.2023;[Epub] CrossRef
Extra-Colonic Malignancy in Inflammatory Bowel Disease: a Paucity of Recommendations with Weak Evidence
Simcha Weissman, Muhammad Aziz, Matthew R. Baniqued, Mohamed Ahmed, Sameh Elias, Joseph D. Feuerstein, James H. Tabibian
Journal of Gastrointestinal Cancer.2022; 53(3): 669. CrossRef
Impact of Inflammatory Bowel Disease (IBD) and IBD Medications on Risk of Hyperlipidemia and in vitro Hepatic Lipogenic-Related Gene Expression: A Population-Based Cohort Study
Ni Tien, Tien-Yuan Wu, Cheng-Li Lin, Chia-Jui Wu, Chung-Y Hsu, Yi-Jen Fang, Yun-Ping Lim
Frontiers in Medicine.2022;[Epub] CrossRef
Real‐world efficacy and safety of vedolizumab among patients with inflammatory bowel disease: A single tertiary medical center experience in Central Taiwan
Yu‐Chiao Chiu, Chia‐Chang Chen, Chung‐Wang Ko, Szu‐Chia Liao, Hong‐Zen Yeh, Chung‐Hsin Chang
Advances in Digestive Medicine.2021; 8(1): 40. CrossRef
Clinical features and treatment of inflammatory bowel disease in a low-incidence area
Hsu-Heng Yen, Tsui-Chun Hsu, Mei-Wen Chen, Pei-Yuan Su, Yang-Yuan Chen
Medicine.2021; 100(10): e25090. CrossRef
Quality assessment of clinical guidelines on probiotics therapy in children with IBD using the AGREE II instrument
Haixin Cheng, Ziyin Ma, Boran Yu, Xiaohui Liu, Chao Tian, Xuli Zhong, Libo Zhao
Journal of Clinical Pharmacy and Therapeutics.2021; 46(4): 1155. CrossRef
Clinicopathological and Molecular Features of Patients with Early and Late Recurrence after Curative Surgery for Colorectal Cancer
Yuan-Tzu Lan, Shih-Ching Chang, Pei-Ching Lin, Chun-Chi Lin, Hung-Hsin Lin, Sheng-Chieh Huang, Chien-Hsing Lin, Wen-Yi Liang, Wei-Shone Chen, Jeng-Kai Jiang, Shung-Haur Yang, Jen-Kou Lin
Cancers.2021; 13(8): 1883. CrossRef
Chinese consensus on diagnosis and treatment in inflammatory bowel disease (2018, Beijing)

Journal of Digestive Diseases.2021; 22(6): 298. CrossRef
Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study
Hsu-Heng Yen, Pei-Yuan Su, Siou-Ping Huang, Lisha Wu, Tsui-Chun Hsu, Ya-Huei Zeng, Yang-Yuan Chen, Wan-Long Chuang
PLOS ONE.2021; 16(5): e0252286. CrossRef
Systematic evaluation of the diagnostic approach of inflammatory bowel disease guidelines
Bing‐He Xiao, Xu‐Dong Ma, Jia‐Jun Lv, Ting Yang, Xin‐Jie Liu, Li‐Ya An, Yu‐Xing Qi, Ming‐Liang Lu, Yong‐Qing Duan, Da‐Li Sun
International Journal of Clinical Practice.2021;[Epub] CrossRef
Clinical significance of granulomas in Crohn's disease: A systematic review and meta‐analysis
Seung Wook Hong, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee, Joo Sung Kim
Journal of Gastroenterology and Hepatology.2020; 35(3): 364. CrossRef
Diagnostic efficacy of double-balloon enteroscopy in patients with suspected isolated small bowel Crohn’s disease
Zihan Huang, Xiang Liu, Fei Yang, Guoxin Wang, Nan Ge, Sheng Wang, Jintao Guo, Siyu Sun
BMC Gastroenterology.2020;[Epub] CrossRef
Incidence of suboptimal response to tumor necrosis factor antagonist therapy in inflammatory bowel disease in newly industrialised countries: The EXPLORE study
Jesus K. Yamamoto-Furusho, Othman Al Harbi, Alessandro Armuzzi, Webber Chan, Enrique Ponce de Leon, Jiaming Qian, Marina Shapina, Murat Toruner, Chia-Hung Tu, Byong Duk Ye, Morgane Guennec, Cecilia Sison, Dirk Demuth, Olga Fadeeva, Qasim M. Rana Khan
Digestive and Liver Disease.2020; 52(8): 869. CrossRef
Strengthened monitoring and optimized management of Crohn’s disease patients
Jing-Jing Wang, Yi-Hong Fan, Rong Huang
World Chinese Journal of Digestology.2020; 28(15): 660. CrossRef
Biologics for the Management of Inflammatory Bowel Disease: A Review in Tuberculosis-Endemic Countries
Rupa Banerjee, Raja Affendi Raja Ali, Shu Chen Wei, Shashi Adsul
Gut and Liver.2020; 14(6): 685. CrossRef
Innovative Animal Model of DSS-Induced Ulcerative Colitis in Pseudo Germ-Free Mice
Sona Gancarcikova, Stanislav Lauko, Gabriela Hrckova, Zuzana Andrejcakova, Vanda Hajduckova, Marian Madar, Livia Kolesar Fecskeova, Dagmar Mudronova, Kristina Mravcova, Gabriela Strkolcova, Radomira Nemcova, Jana Kacirova, Andrea Staskova, Stefan Vilcek,
Cells.2020; 9(12): 2571. CrossRef
Inflammatory bowel disease and its treatment in 2018: Global and Taiwanese status updates
Hau-Jyun Su, Yu-Tse Chiu, Chuan-Tai Chiu, Yen-Chun Lin, Chen-Yu Wang, Jui-Ying Hsieh, Shu-Chen Wei
Journal of the Formosan Medical Association.2019; 118(7): 1083. CrossRef
Epidemiological trend in inflammatory bowel disease in Taiwan from 2001 to 2015: a nationwide populationbased study
Hsu-Heng Yen, Meng-Tzu Weng, Chien-Chih Tung, Yu-Ting Wang, Yuan Ting Chang, Chin-Hao Chang, Ming-Jium Shieh, Jau-Min Wong, Shu-Chen Wei
Intestinal Research.2019; 17(1): 54. CrossRef
Response to Chamberlin and Borody
Gary R. Lichtenstein, Edward V. Loftus, Kim L. Isaacs, Miguel D. Regueiro, Bruce E. Sands
American Journal of Gastroenterology.2019; 114(1): 171. CrossRef
Immunogenicity of biologic therapies: causes and consequences
Wolf-Henning Boehncke, Nicolo Costantino Brembilla
Expert Review of Clinical Immunology.2018; 14(6): 513. CrossRef
Changing treatment paradigms for the management of inflammatory bowel disease
Jong Pil Im, Byong Duk Ye, You Sun Kim, Joo Sung Kim
The Korean Journal of Internal Medicine.2018; 33(1): 28. CrossRef
Changes in hepatitis B virus surface antibody titer and risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients undergoing biologic therapy for rheumatic diseases: a prospective cohort study
Ya-Chih Tien, Hsu-Heng Yen, Ching-Fang Li, Mei-Ping Liu, Yin-Tzu Hsue, Ming-Hui Hung, Ying-Ming Chiu
Arthritis Research & Therapy.2018;[Epub] CrossRef
Balloon-Assisted Enteroscopy and Capsule Endoscopy in Suspected Small Bowel Crohn’s Disease
Hsu-Heng Yen, Chen-Wang Chang, Jen-Wei Chou, Shu-Chen Wei
Clinical Endoscopy.2017; 50(5): 417. CrossRef

17,388 View
162 Download
29 Web of Science
30 Crossref

Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease: Shu-Chen Wei, Ting-An Chang, Te-Hsin Chao, Jinn-Shiun Chen, Jen-Wei Chou, Yenn-Hwei Chou, Chiao-Hsiung Chuang, Wen-Hung Hsu, Tien-Yu Huang, Tzu-Chi Hsu, Chun-Chi Lin, Hung-Hsin Lin, Jen-Kou Lin, Wei-Chen Lin, Yen-Hsuan Ni, Ming-Jium Shieh, I-Lun Shih, Chia-Tung Shun, Yuk-Ming Tsang, Cheng-Yi Wang, Horng-Yuan Wang, Meng-Tzu Weng, Deng-Chyang Wu, Wen-Chieh Wu, Hsu-Heng Yen, Jau-Min Wong; Intest Res 2017;15(3):266-284. Published online June 12, 2017; DOI: https://doi.org/10.5217/ir.2017.15.3.266

Abstract PDF PubReader ePub

Ulcerative colitis (UC) is an inflammatory bowel disease characterized by chronic mucosal inflammation of the colon, and the prevalence and incidence of UC have been steadily increasing in Taiwan. A steering committee was established by the Taiwan Society of Inflammatory Bowel Disease to formulate statements on the diagnosis and management of UC taking into account currently available evidence and the expert opinion of the committee. Accurate diagnosis of UC requires thorough clinical, endoscopic, and histological assessment and careful exclusion of differential diagnoses, particularly infectious colitis. The goals of UC therapy are to induce and maintain remission, reduce the risk of complications, and improve quality of life. As outlined in the recommended treatment algorithm, choice of treatment is dictated by severity, extent, and course of disease. Patients should be evaluated for hepatitis B virus and tuberculosis infection prior to immunosuppressive treatment, especially with steroids and biologic agents, and should be regularly monitored for reactivation of latent infection. These consensus statements are also based on current local evidence with consideration of factors, and could be serve as concise and practical guidelines for supporting clinicians in the management of UC in Taiwan.

Citations

Citations to this article as recorded by

Factors affecting perception and acceptance of colonoscopy in patients with inflammatory bowel disease
Chang-Hung Liao, Peng-Jen Chen, Yu-Lueng Shih, Wei-Kuo Chang, Tsai-Yuan Hsieh, Tien-Yu Huang
Preventive Medicine Reports.2025; 49: 102951. CrossRef
Clinical Characteristics, Management, and Outcomes of Colitis-Associated Colorectal Cancer and the Comparison With Sporadic Colorectal Cancer in Taiwan
Hsin-Yun Wu, Meng-Tzu Weng, Jen-Wei Chou, Hsu-Heng Yen, Chun-Chi Lin, Feng-Fan Chiang, Chen-Shuan Chung, Wei-Chen Lin, Chen-Wang Chang, Puo-Hsien Le, Chia-Jung Kuo, Ching-Pin Lin, Wen-Hung Hsu, Chiao-Hsiung Chuang, Tzung-Jiun Tsai, I-Che Feng, Shu-Chen We
Clinical and Translational Gastroenterology.2025; 16(2): e00798. CrossRef
Moxifloxacin promotes two-photon microscopic imaging for discriminating different stages of DSS-induced colitis on mice
Yingtong Chen, Xiaoyi Xu, Min Wang, Xiang Wang, Yan Wang, Yong Zhang, Jin Huang, Yuwen Tao, Wentao Fan, Lili Zhao, Li Liu, Zhining Fan
Photodiagnosis and Photodynamic Therapy.2024; 48: 104220. CrossRef
High prevalence of vitamin D deficiency in Taiwanese patients with inflammatory bowel disease
Chen-Ta Yang, Hsu-Heng Yen, Pei-Yuan Su, Yang-Yuan Chen, Siou-Ping Huang
Scientific Reports.2024;[Epub] CrossRef
Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023
Hsu-Heng Yen, Jia-Feng Wu, Horng-Yuan Wang, Ting-An Chang, Chung-Hsin Chang, Chen-Wang Chang, Te-Hsin Chao, Jen-Wei Chou, Yenn-Hwei Chou, Chiao-Hsiung Chuang, Wen-Hung Hsu, Tzu-Chi Hsu, Tien-Yu Huang, Tsung-I Hung, Puo-Hsien Le, Chun-Che Lin, Chun-Chi Lin
Intestinal Research.2024; 22(3): 213. CrossRef
Systemic Immune-Inflammation Index: Unveiling the Diagnostic Potential in Ulcerative Colitis through a Comprehensive Systematic Review and Meta-Analysis
Anas Elgenidy, Omar Alomari, Tasbih Emad, Sara K. Kamal, Islam E. Al Ghanam, Aya Sherif, Mohammed Al-mahdi Al-kurdi, Abdallah A. Helal, Yusof Mohamed Omar, Mohamed Rafiek Ramadan
Gastroenterology & Endoscopy.2024;[Epub] CrossRef
Real‐world experience of adalimumab therapy for patients with ulcerative colitis: A single tertiary medical center experience in Central Taiwan
Hsu‐Heng Yen, Yu‐Chun Hsu, Chu‐Hsuan Kuo, Tsui‐Chun Hsu, Yang‐Yuan Chen
Advances in Digestive Medicine.2023; 10(1): 28. CrossRef
Improvement of ulcerative colitis control by searching and restricting of inflammatory trigger factors in daily clinical practice
Kun-Yu Tsai, Jeng-Fu You, Tzong-Yun Tsai, Yih Jong Chern, Yu-Jen Hsu, Shu-Huan Huang, Wen-Sy Tsai
Intestinal Research.2023; 21(1): 100. CrossRef
Real-World Evidence of Effectiveness and Safety of Vedolizumab for Inflammatory Bowel Disease in Taiwan: A Prospective Nationwide Registry (VIOLET) Study
Wei-Chen Lin, Wei-Chen Tai, Chung-Hsin Chang, Chia-Hung Tu, I-Che Feng, Ming-Jium Shieh, Chen-Shuan Chung, Hsu-Heng Yen, Jen-Wei Chou, Jau-Min Wong, Yu-Hwa Liu, Tien-Yu Huang, Chiao-Hsiung Chuang, Tzung-Jiun Tsai, Feng-Fan Chiang, Chien-Yu Lu, Wen-Hung Hs
Inflammatory Bowel Diseases.2023; 29(11): 1730. CrossRef
Health Maintenance and Preventative Care in Inflammatory Bowel Disease
Simcha Weissman, Hannah K. Systrom, Ayrton Bangolo, Daniel Elias, Marcel Awasi, Tamer Zahdeh, Chukwuemeka E. Ogbu, Mishka Hoo Kim, Meenal Kalra, Kavya Khota, Ritu B. Kasarapu, Erasmus Mutabi, Moinulhaq Makrani, Sanskrita Nemalikanti, Jim Thomas, Joseph P.
Journal of Clinical Gastroenterology.2023; 57(4): 325. CrossRef
Treatment of inflammatory bowel disease–Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn’s and Colitis meeting
Eun Mi Song, Soo-Young Na, Sung Noh Hong, Siew Chien Ng, Tadakazu Hisamatsu, Byong Duk Ye
Intestinal Research.2023; 21(3): 339. CrossRef
Association between ulcerative colitis and Helicobacter pylori infection: A case-control study
Iyad Ali, Qusay Abdo, Shayma'a M. Al-Hihi, Ansam Shawabkeh
Heliyon.2022; 8(2): e08930. CrossRef
Impact of Inflammatory Bowel Disease (IBD) and IBD Medications on Risk of Hyperlipidemia and in vitro Hepatic Lipogenic-Related Gene Expression: A Population-Based Cohort Study
Ni Tien, Tien-Yuan Wu, Cheng-Li Lin, Chia-Jui Wu, Chung-Y Hsu, Yi-Jen Fang, Yun-Ping Lim
Frontiers in Medicine.2022;[Epub] CrossRef
Discovery and Validation of Potential Serum Biomarkers with Pro-Inflammatory and DNA Damage Activities in Ulcerative Colitis: A Comprehensive Untargeted Metabolomic Study
Mingxiao Li, Rui Zhang, Mingjie Xin, Yi Xu, Shijia Liu, Boyang Yu, Boli Zhang, Jihua Liu
Metabolites.2022; 12(10): 997. CrossRef
Chemoprevention of Colitis-Associated Dysplasia or Cancer in Inflammatory Bowel Disease
Shun-Wen Hsiao, Hsu-Heng Yen, Yang-Yuan Chen
Gut and Liver.2022; 16(6): 840. CrossRef
Serum homocysteine level was elevated in ulcerative colitis and can be applied as diagnostic biomarker
Xiaoping Zhang, Shanshan Wang, Hongmin Wang, Junxia Wu, Qihua Tan
Pteridines.2022; 33(1): 87. CrossRef
Real‐world efficacy and safety of vedolizumab among patients with inflammatory bowel disease: A single tertiary medical center experience in Central Taiwan
Yu‐Chiao Chiu, Chia‐Chang Chen, Chung‐Wang Ko, Szu‐Chia Liao, Hong‐Zen Yeh, Chung‐Hsin Chang
Advances in Digestive Medicine.2021; 8(1): 40. CrossRef
Clinical features and treatment of inflammatory bowel disease in a low-incidence area
Hsu-Heng Yen, Tsui-Chun Hsu, Mei-Wen Chen, Pei-Yuan Su, Yang-Yuan Chen
Medicine.2021; 100(10): e25090. CrossRef
Comparison of outcomes of cyclosporine A and infliximab for steroid‐refractory acute severe ulcerative colitis
Eun Mi Song, Eun Hye Oh, Sung Wook Hwang, Sang Hyoung Park, Dong‐Hoon Yang, Jeong‐Sik Byeon, Seung‐Jae Myung, Suk‐Kyun Yang, Byong Duk Ye
Journal of Gastroenterology and Hepatology.2021; 36(9): 2463. CrossRef
Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study
Hsu-Heng Yen, Pei-Yuan Su, Siou-Ping Huang, Lisha Wu, Tsui-Chun Hsu, Ya-Huei Zeng, Yang-Yuan Chen, Wan-Long Chuang
PLOS ONE.2021; 16(5): e0252286. CrossRef
Systematic evaluation of the diagnostic approach of inflammatory bowel disease guidelines
Bing‐He Xiao, Xu‐Dong Ma, Jia‐Jun Lv, Ting Yang, Xin‐Jie Liu, Li‐Ya An, Yu‐Xing Qi, Ming‐Liang Lu, Yong‐Qing Duan, Da‐Li Sun
International Journal of Clinical Practice.2021;[Epub] CrossRef
Probiotic-Induced Tolerogenic Dendritic Cells: A Novel Therapy for Inflammatory Bowel Disease?
Shaghayegh Baradaran Ghavami, Hamid Asadzadeh Aghdaei, Dario Sorrentino, Shabnam Shahrokh, Maryam Farmani, Fatemeh Ashrafian, Maria Pina Dore, Shahrbanoo Keshavarz Azizi Raftar, Seyed Mobin Khoramjoo, Mohammad Reza Zali
International Journal of Molecular Sciences.2021; 22(15): 8274. CrossRef
Efficacy and safety of Etiasa for treatment of mild-to-moderate ulcerative colitis: A Meta-analysis
Fang-Mei Ling, Fei-Nan Lu, Sheng-Nan Wang, Liang-Ru Zhu
World Chinese Journal of Digestology.2021; 29(15): 880. CrossRef
Association between Ulcerative Colitis and Helicobacter pylori Infection: A Case-Control Study
Iyad Ali, Qusay Abdo, Shayma’a M. Al-Hihi, Ansam Shawabkeh
SSRN Electronic Journal .2021;[Epub] CrossRef
A case with cytomegalovirus colitis and toxic megacolon initially diagnosed as Crohn's disease
Shan-Han Chang, Hsin-Yun Sun, Chia-Tung Shun, Shu-Chen Wei
Journal of the Formosan Medical Association.2020; 119(9): 1442. CrossRef
Incidence of suboptimal response to tumor necrosis factor antagonist therapy in inflammatory bowel disease in newly industrialised countries: The EXPLORE study
Jesus K. Yamamoto-Furusho, Othman Al Harbi, Alessandro Armuzzi, Webber Chan, Enrique Ponce de Leon, Jiaming Qian, Marina Shapina, Murat Toruner, Chia-Hung Tu, Byong Duk Ye, Morgane Guennec, Cecilia Sison, Dirk Demuth, Olga Fadeeva, Qasim M. Rana Khan
Digestive and Liver Disease.2020; 52(8): 869. CrossRef
Predictive values of stool-based tests for mucosal healing among Taiwanese patients with ulcerative colitis: a retrospective cohort analysis
Hsu-Heng Yen, Mei-Wen Chen, Yu-Yao Chang, Hsuan-Yuan Huang, Tsui-Chun Hsu, Yang-Yuan Chen
PeerJ.2020; 8: e9537. CrossRef
Ulcerative colitis
Taku Kobayashi, Britta Siegmund, Catherine Le Berre, Shu Chen Wei, Marc Ferrante, Bo Shen, Charles N. Bernstein, Silvio Danese, Laurent Peyrin-Biroulet, Toshifumi Hibi
Nature Reviews Disease Primers.2020;[Epub] CrossRef
Biologics for the Management of Inflammatory Bowel Disease: A Review in Tuberculosis-Endemic Countries
Rupa Banerjee, Raja Affendi Raja Ali, Shu Chen Wei, Shashi Adsul
Gut and Liver.2020; 14(6): 685. CrossRef
To assess the effective and safety of berberine hydrochloride in ulcerative colitis
Yong Zhang, Jin Wang, Daorui Hou, Shuguang Yan, Sijie Dang
Medicine.2020; 99(49): e23482. CrossRef
Inflammatory bowel disease and its treatment in 2018: Global and Taiwanese status updates
Hau-Jyun Su, Yu-Tse Chiu, Chuan-Tai Chiu, Yen-Chun Lin, Chen-Yu Wang, Jui-Ying Hsieh, Shu-Chen Wei
Journal of the Formosan Medical Association.2019; 118(7): 1083. CrossRef
Epidemiological trend in inflammatory bowel disease in Taiwan from 2001 to 2015: a nationwide populationbased study
Hsu-Heng Yen, Meng-Tzu Weng, Chien-Chih Tung, Yu-Ting Wang, Yuan Ting Chang, Chin-Hao Chang, Ming-Jium Shieh, Jau-Min Wong, Shu-Chen Wei
Intestinal Research.2019; 17(1): 54. CrossRef
Adherence to Asacol once daily versus divided regimen for maintenance therapy in ulcerative colitis: a prospective, multicenter, randomized study
Soo-Kyung Park, Sang Hyun Park, Chang Soo Eun, Geom Seog Seo, Jong Pil Im, Tae Oh Kim, Dong-Il Park
Intestinal Research.2019; 17(3): 349. CrossRef
Effectiveness of sigmoidoscopy for assessing ulcerative colitis disease activity and therapeutic response
Wei-Chen Lin, Chen-Wang Chang, Ming-Jen Chen, Tzu-Chi Hsu, Horng-Yuan Wang
Medicine.2019; 98(21): e15748. CrossRef
Ulcerative Colitis in Elderly People: An Emerging Issue
Wei-Chen Lin, Ming-Jen Chen, Cheng-Hsin Chu, Tsang-En Wang, Horng-Yuan Wang, Chen-Wang Chang
International Journal of Gerontology.2018;[Epub] CrossRef
Response to hepatitis B vaccination in patients with inflammatory bowel disease: a prospective observational study in Korea
Ji Young Chang, Sung-Ae Jung, Chang Mo Moon, Seong-Eun Kim, Hye-Kyung Jung, Ki-Nam Shim
Intestinal Research.2018; 16(4): 599. CrossRef
Efficacy and Safety of Hou Gu Mi Xi on Spleen Qi Deficiency in Patients with Nonorganic Gastrointestinal Disorders: Protocol for a Multicenter, Randomized, Placebo‐Controlled Trial
Xiaofan Chen, Heyun Nie, Wenjun Liu, Xu Zhou, Jianhua Nie, Bin Xie, Dongping Chen, Yiping Jiang, Kunhe Zhang, Ying Fu, Deping Yang, Yan Xiong, Zhangyang Zhao, Xin Sun, Weifeng Zhu, Carmen Mannucci
Evidence-Based Complementary and Alternative Medicine.2018;[Epub] CrossRef
Challenges in the diagnosis of ulcerative colitis with concomitant bacterial infections and chronic infectious colitis
Wei-Chen Lin, Chen-Wang Chang, Ming-Jen Chen, Cheng-Hsin Chu, Shou-Chuan Shih, Tzu-Chi Hsu, Horng-Yang Wang, John Green
PLOS ONE.2017; 12(12): e0189377. CrossRef

13,150 View
225 Download
39 Web of Science
38 Crossref

Intestinal Stricture in Crohn's Disease: Chen-Wang Chang, Jau-Min Wong, Chien-Chih Tung, I-Lun Shih, Horng-Yuan Wang, Shu-Chen Wei; Intest Res 2015;13(1):19-26. Published online January 29, 2015; DOI: https://doi.org/10.5217/ir.2015.13.1.19

Abstract PDF PubReader

Crohn's disease (CD) is a disease with chronic inflammation of unknown etiology involving any part of the gastrointestinal tract. The incidence and prevalence of CD are increasing recently in Asia. Half of the CD patients will have intestinal complications, such as strictures or fistulas, within 20 years after diagnosis. Twenty-five percentage of CD patients have had at least one small bowel stricture and 10% have had at least one colonic stricture and lead to significant complications. Most of these patients will require at least one surgery during their lifetime. Early diagnosis and evaluation with adequate managements for the patients can prevent disability and mortality of these patient. Here, we reviewed the current incidence of CD with stricture, the etiology of stricture, and how to diagnose and manage the stricture.

Citations

Citations to this article as recorded by

Colonic strictures in Crohn’s disease: a non-surgical survival
Sarra Laabidi, Hamed Aboubecrine, Salma Souissi, Donia Gouiaa, Asma Labidi, Nadia Ben Mustapha, Anis Haddad, Amine Sebai, Meriem Serghini, Monia Fekih, Hanene Jaziri, Jalel Boubaker
Future Science OA.2025;[Epub] CrossRef
Enteroscopic Balloon Dilation in Small Bowel Stricturing Crohn’s Disease: Long‐Term Outcomes and Risk Factors for Surgery in a Single‐Center Prospective Observational Study
Sung Noh Hong, Ji Eun Kim, Eun Ran Kim, Dong Kyung Chang, Young‐Ho Kim
United European Gastroenterology Journal.2025;[Epub] CrossRef
Duodenal Crohn’s disease: Case report and systematic review
Muniratu Amadu, Jonathan Soldera
World Journal of Methodology.2024;[Epub] CrossRef
Infective Endocarditis After Endoscopic Stricture Dilation in Crohn's Disease
André Gonçalves, Sandra Barbeiro, Carina Leal, Antonieta Santos, Helena Vasconcelos
ACG Case Reports Journal.2024; 11(6): e01377. CrossRef
Association between nutritional status assessed by body mass index and Crohn's disease phenotype: A Nation-wide analysis
Judwin Ndzo, Sudheer K. Vuyyuru, Thomas Trimble, Kaung Yan, Grazziela Figueredo, Gordon W. Moran
Clinical Nutrition ESPEN.2024; 64: 290. CrossRef
Perioperative optimization of Crohn's disease
Chun‐Chi Lin, Hung‐Hsin Lin, Hui‐Chuen Chen, Nai‐Chia Chen, I‐Lun Shih, Ji‐Shiang Hung, Te‐Cheng Yueh, Feng‐Fan Chiang, Ping‐Wei Lin, Yuan‐Yao Tsai, Shu‐Chen Wei
Annals of Gastroenterological Surgery.2023; 7(1): 10. CrossRef
Treatment escalation and de-escalation decisions in Crohn’s disease: Delphi consensus recommendations from Japan, 2021
Hiroshi Nakase, Motohiro Esaki, Fumihito Hirai, Taku Kobayashi, Katsuyoshi Matsuoka, Minoru Matsuura, Makoto Naganuma, Masayuki Saruta, Kiichiro Tsuchiya, Motoi Uchino, Kenji Watanabe, Tadakazu Hisamatsu, Akira Andoh, Shigeki Bamba, Motohiro Esaki, Mikihi
Journal of Gastroenterology.2023; 58(4): 313. CrossRef
Ileocecal valve that cannot be intubated in Crohn’s disease: is this a sign of poor prognosis?
Muhammed Bahaddin Durak, Cem Simsek, Bayram İnan, Ilhami Yuksel
International Journal of Colorectal Disease.2023;[Epub] CrossRef
Effects of Mimosa caesalpiniifolia pre-formulation on the intestinal barrier during sodium dextran sulfate-induced colitis in Wistar rats
Aline Garnevi-Fávero , Karina Nascimento-da Silva , Willian Rodrigues-Ribeiro , Caroline Marcantonio-Ferreira , Patrícia Sartorelli, Leonardo Cardili, Rita De Cássia-Sinigaglia , Joice Naiara Bertaglia-Pereira, Marcelo Aparecido-da Silva , Wagner Vilega
Biomédica.2023; 43(2): 282. CrossRef
Small Bowel Imaging from Stepchild of Roentgenology to MR Enterography: Part I: Guidance in Performing and Observing Normal and Abnormal Imaging Findings
Antonio Pierro, Laura Maria Minordi, Luigi Larosa, Giulia Guerri, Alessandro Grimaldi, Fabio Quinto, Fabio Rotondi, Annalisa Marcellino, Teresa Bevere, Raffaella Basilico, Roberto Iezzi, Savino Cilla
Life.2023; 13(8): 1691. CrossRef
Small Bowel Imaging from Stepchild of Roentgenology to MR Enterography, Part II: The Reliable Disclosure of Crohn’s Disease and Non-Inflammatory Small Bowel Disorder Plot through MRI Findings
Antonio Pierro, Laura Maria Minordi, Luigi Larosa, Carla Cipri, Giulia Guerri, Fabio Quinto, Fabio Rotondi, Annalisa Marcellino, Raffaella Basilico, Roberto Iezzi, Savino Cilla
Life.2023; 13(9): 1836. CrossRef
Use of oral diet and nutrition support in management of stricturing and fistulizing Crohn's disease
Kush Fansiwala, Neha D. Shah, Kelly A. McNulty, Mary R. Kwaan, Berkeley N. Limketkai
Nutrition in Clinical Practice.2023; 38(6): 1282. CrossRef
Congenital Partial Colonic Agenesis in Dogs and Cats: Clinical, Biological, Diagnostic Imaging, Endoscopic and Histopathologic Characterization, a Retrospective Study
Paul Remmel, Lucile Gros, Jérémy Mortier, Valérie Freiche
Veterinary Sciences.2023; 10(9): 577. CrossRef
Revisiting fibrosis in inflammatory bowel disease: the gut thickens
Silvia D’Alessio, Federica Ungaro, Daniele Noviello, Sara Lovisa, Laurent Peyrin-Biroulet, Silvio Danese
Nature Reviews Gastroenterology & Hepatology.2022; 19(3): 169. CrossRef
Medical treatment of intestinal Crohn's disease
Eula Plana Tetangco, Adam C. Stein
Seminars in Colon and Rectal Surgery.2022; 33(1): 100862. CrossRef
Choosing the right biologic for complications of inflammatory bowel disease
Shana Rakowsky, Konstantinos Papamichael, Adam S. Cheifetz
Expert Review of Gastroenterology & Hepatology.2022; 16(3): 235. CrossRef
The Possible Pathogenic Role of IgG4-Producing Plasmablasts in Stricturing Crohn’s Disease
Omar Bushara, David Joseph Escobar, Samuel Edward Weinberg, Leyu Sun, Jie Liao, Guang-Yu Yang
Pathobiology.2022; 89(4): 187. CrossRef
Safety and efficacy of non-fluoroscopic endoscopic dilatation of gastrointestinal tuberculosis related strictures
Pankaj Kumar, Anuraag Jena, Chhagan Lal Birda, Harjeet Singh, Pankaj Gupta, Kaushal Kishor Prasad, Usha Dutta, Vishal Sharma
BMC Gastroenterology.2022;[Epub] CrossRef
Endoscopic balloon dilations for strictures of rectum, ileocecal valve and duodenum in a patient with X-linked inhibitor of apoptosis deficiency: a case report
Shinsuke Otagiri, Takehiko Katsurada, Kensuke Sakurai, Junichi Sugita, Naoya Sakamoto
Intestinal Research.2022; 20(2): 274. CrossRef
State-of-the-art surgery for Crohn’s disease: Part II—colonic Crohn’s disease and associated neoplasms
Anne Macleod, Sandra L. Kavalukas, Katharina M. Scheurlen, Susan Galandiuk
Langenbeck's Archives of Surgery.2022; 407(7): 2595. CrossRef
The role of interleukin-33 in organ fibrosis
Samuele Di Carmine, Molly M Scott, Mairi H McLean, Henry J McSorley
Discovery Immunology.2022;[Epub] CrossRef
Late onset crohns ileitis—A diagnostic dilemma
Ashok Sunder, Manish Kumar, Sudip Saha, Bhagyalakshmi Satyanarayan
Journal of Family Medicine and Primary Care.2022; 11(12): 7968. CrossRef
Inhibition of APE1/Ref-1 Redox Signaling Alleviates Intestinal Dysfunction and Damage to Myenteric Neurons in a Mouse Model of Spontaneous Chronic Colitis
Lauren Sahakian, Rhiannon T Filippone, Rhian Stavely, Ainsley M Robinson, Xu Sean Yan, Raquel Abalo, Rajaraman Eri, Joel C Bornstein, Mark R Kelley, Kulmira Nurgali
Inflammatory Bowel Diseases.2021; 27(3): 388. CrossRef
A postdischarge venous thromboembolism risk calculator for inflammatory bowel disease surgery
Cary Jo R. Schlick, Tarik K. Yuce, Anthony D. Yang, Michael F. McGee, David J. Bentrem, Karl Y. Bilimoria, Ryan P. Merkow
Surgery.2021; 169(2): 240. CrossRef
Presence of Obstructive Symptoms and Absence of Perianal Crohn Disease Is Predictive of Surgery After Endoscopic Balloon Dilation
Barathi Sivasailam, Scott Manski, Alicia Wentz, Raymond K Cross
Inflammatory Bowel Diseases.2021; 27(8): 1230. CrossRef
Association of Baseline Luminal Narrowing With Ileal Microbial Shifts and Gene Expression Programs and Subsequent Transmural Healing in Pediatric Crohn Disease
Allison D Ta, Nicholas J Ollberding, Rebekah Karns, Yael Haberman, Adina L Alazraki, David Hercules, Robert Baldassano, James Markowitz, Melvin B Heyman, Sandra Kim, Barbara Kirschner, Jason M Shapiro, Joshua Noe, Maria Oliva-Hemker, Anthony Otley, Marian
Inflammatory Bowel Diseases.2021; 27(11): 1707. CrossRef
Infliximab therapy intensification based on endoscopic activity is related to suppress treatment discontinuation in patients with Crohn disease
Yuga Komaki, Shuji Kanmura, Kazuki Yutsudo, Kosuke Kuwazuru, Fukiko Komaki, Akihito Tanaka, Nobuaki Nishimata, Yoichi Sameshima, Fumisato Sasaki, Hidehisa Ohi, Yuichi Nakamura, Koichi Tokushige, Yukinori Sameshima, Akio Ido
Medicine.2021; 100(6): e24731. CrossRef
Duodenal Obstruction in a Patient Previously Treated With EndoVascular Aneurysm Sealing System Repair
Carlo Biddau, Carlo Nagliati, Michele Graziano, Lorenzo Cereser, Giovanni Terrosu, Alessandro Balani
Vascular and Endovascular Surgery.2021; 55(8): 859. CrossRef
Crohn's Disease Obstructions
Molly M. Ford
Clinics in Colon and Rectal Surgery.2021; 34(04): 227. CrossRef
Transplantation of fecal microbiota from patients with inflammatory bowel disease and depression alters immune response and behavior in recipient mice
Hyo-Min Jang, Jeon-Kyung Kim, Min-Kyung Joo, Yoon-Jung Shin, Chang Kyun Lee, Hyo-Jong Kim, Dong-Hyun Kim
Scientific Reports.2021;[Epub] CrossRef
Crohn’s disease at radiological imaging: focus on techniques and intestinal tract
Giuseppe Cicero, Silvio Mazziotti
Intestinal Research.2021; 19(4): 365. CrossRef
Current Topics of the Mechanism of Intestinal Fibrosis in Crohn’s Disease
Yusuke Honzawa, Shuji Yamamoto, Makoto Okabe, Hiroshi Seno, Hiroshi Nakase
Immuno.2021; 1(4): 574. CrossRef
Worse outcomes and higher costs of care in fibrostenotic Crohn’s disease: a real-world propensity-matched analysis in the USA
Melody Dehghan, Gabriel Wong, Edward Neuberger, Cindy Kin, Florian Rieder, K T Park
BMJ Open Gastroenterology.2021; 8(1): e000781. CrossRef
Epidemiology of fibrostenosing inflammatory bowel disease
Joyce Wing Yan Mak, Siew Chien Ng
Journal of Digestive Diseases.2020; 21(6): 332. CrossRef
The Efficacy of Anti-Tumor Necrosis Factor Alpha for Symptomatic Stricturing Small Bowel Crohn’s Disease
Mansour Alourfi, Mahmoud Mosli, Omar I Saadah
Cureus.2020;[Epub] CrossRef
Roles of protein ubiquitination in inflammatory bowel disease
Yue Xiao, Qi Huang, Zherui Wu, Weilin Chen
Immunobiology.2020; 225(6): 152026. CrossRef
Chirurgie des maladies inflammatoires chroniques de l’intestin
M. Aubert, D. Mege, L. Maggiori, Y. Panis
EMC - Gastro-entérologie.2020; 37(3): 1. CrossRef
Development, validation, and application of a novel tool to measure disease-related knowledge in patients with inflammatory bowel disease
Hyuk Yoon, Suk-Kyun Yang, Hoonsub So, Ko Eun Lee, Sang Hyoung Park, Sung-Ae Jung, Joong Haeng Choh, Cheol Min Shin, Young Soo Park, Nayoung Kim, Dong Ho Lee
The Korean Journal of Internal Medicine.2019; 34(1): 81. CrossRef
Unusual causes of large bowel obstruction
Nicholas G. Farkas, Ted Joseph P. Welman, Talisa Ross, Sarah Brown, Jason J. Smith, Nikhil Pawa
Current Problems in Surgery.2019; 56(2): 49. CrossRef
TTC7A: Steward of Intestinal Health
Sasha Jardine, Neel Dhingani, Aleixo M. Muise
Cellular and Molecular Gastroenterology and Hepatology.2019; 7(3): 555. CrossRef
Segmental dilatation following side‐to‐side isoperistaltic strictureplasty in Crohn’s disease: a note of caution
Brendan Desmond, Ashok Gunawardene, Ben Griffiths, John Keating
ANZ Journal of Surgery.2019;[Epub] CrossRef
Small bowel strictures
Deniz Durmush, Arthur J. Kaffes
Current Opinion in Gastroenterology.2019; 35(3): 235. CrossRef
Early Initiation of Anti-TNF is Associated with Favourable Long-term Outcome in Crohn’s Disease: 10-Year-Follow-up Data from the Swiss IBD Cohort Study
Roy Frei, Nicolas Fournier, Jonas Zeitz, Michael Scharl, Bernhard Morell, Thomas Greuter, Philipp Schreiner, Benjamin Misselwitz, Ekaterina Safroneeva, Alain M Schoepfer, Stephan R Vavricka, Gerhard Rogler, Luc Biedermann
Journal of Crohn's and Colitis.2019; 13(10): 1292. CrossRef
Clinical Features and Prognosis of Crohn’s Disease with Upper Gastrointestinal Tract Phenotype in Chinese Patients
Xiao-Wei Sun, Juan Wei, Zhao Yang, Xin-Xin Jin, Hai-Jun Wan, Bo-Si Yuan, Miao-Fang Yang, Jiong Liu, Fang-Yu Wang
Digestive Diseases and Sciences.2019; 64(11): 3291. CrossRef
Phosphatidylinositol 3-kinase p110δ drives intestinal fibrosis in SHIP deficiency
Young Lo, Jean Philippe Sauve, Susan C. Menzies, Theodore S. Steiner, Laura M. Sly
Mucosal Immunology.2019; 12(5): 1187. CrossRef
Occult Adenocarcinoma Arising in Crohn’s-Related Strictures: A Case Series
Kevin Singh, Amandeep Singh, Jessica Philpott, David Liska, Keith Lai
Crohn's & Colitis 360.2019;[Epub] CrossRef
Agentes anti-factor de necrosis tumoral en enfermedad de Crohn y colitis ulcerosa: más allá de la enfermedad luminal
Laura Núñez-Gómez, Francisco Mesonero-Gismero, Agustín Albillos-Martínez, Antonio López-Sanromán
Gastroenterología y Hepatología.2018; 41(9): 576. CrossRef
Parathyroid Hormone–Like Hormone Induces Epithelial-to-Mesenchymal Transition of Intestinal Epithelial Cells by Activating the Runt-Related Transcription Factor 2
Shuying He, Minmin Xue, Cuiping Liu, Fang Xie, Lan Bai
The American Journal of Pathology.2018; 188(6): 1374. CrossRef
Anti-tumour necrosis factor agents in Crohn's disease and ulcerative colitis: Beyond luminal disease
Laura Núñez-Gómez, Francisco Mesonero-Gismero, Agustín Albillos-Martínez, Antonio López-Sanromán
Gastroenterología y Hepatología (English Edition).2018; 41(9): 576. CrossRef
Long-Term Outcomes of Endoscopic Balloon Dilation for Benign Strictures in Patients with Inflammatory Bowel Disease
Hye Won Lee, Soo Jung Park, Seong Ran Jeon, Byong Duk Ye, Jae Jun Park, Jae Hee Cheon, Tae Il Kim, Won Ho Kim
Gut and Liver.2018; 12(5): 530. CrossRef
Association of Perianal Fistulas with Clinical Features and Prognosis of Crohn's Disease in Korea: Results from the CONNECT Study
Jaeyoung Chun, Jong Pil Im, Ji Won Kim, Kook Lae Lee, Chang Hwan Choi, Hyunsoo Kim, Jae Hee Cheon, Byong Duk Ye, Young-Ho Kim, You Sun Kim, Yoon Tae Jeen, Dong Soo Han, Won Ho Kim, Joo Sung Kim
Gut and Liver.2018; 12(5): 544. CrossRef
Computed tomography and magnetic resonance imaging in the diagnosis of the small and large intestine strictures in Crohn’s disease. Radiological semiotics and assessment of the inflammation activity
S. E. Dubrova, G. A. Stashuk, N. V. Nikitina, Yu. K. Bogomazov
Almanac of Clinical Medicine.2018; 46(7): 725. CrossRef
A distinct epigenetic profile distinguishes stenotic from non-inflamed fibroblasts in the ileal mucosa of Crohn’s disease patients
Andrew Y. F. Li Yim, Jessica R. de Bruyn, Nicolette W. Duijvis, Catriona Sharp, Enrico Ferrero, Wouter J. de Jonge, Manon E. Wildenberg, Marcel M. A. M. Mannens, Christianne J. Buskens, Geert R. D’Haens, Peter Henneman, Anje A. te Velde, Osman El-Maarri
PLOS ONE.2018; 13(12): e0209656. CrossRef
Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease
Shu-Chen Wei, Ting-An Chang, Te-Hsin Chao, Jinn-Shiun Chen, Jen-Wei Chou, Yenn-Hwei Chou, Chiao-Hsiung Chuang, Wen-Hung Hsu, Tien-Yu Huang, Tzu-Chi Hsu, Chun-Chi Lin, Hung-Hsin Lin, Jen-Kou Lin, Wei-Chen Lin, Yen-Hsuan Ni, Ming-Jium Shieh, I-Lun Shih, Chi
Intestinal Research.2017; 15(3): 285. CrossRef
Biodegradable Stents
Deepanshu Jain, Ejaz Mahmood, Shashideep Singhal
Journal of Clinical Gastroenterology.2017; 51(4): 295. CrossRef
Quality Indicators for Small Bowel Capsule Endoscopy
Ki-Nam Shim, Seong Ran Jeon, Hyun Joo Jang, Jinsu Kim, Yun Jeong Lim, Kyeong Ok Kim, Hyun Joo Song, Hyun Seok Lee, Jae Jun Park, Ji Hyun Kim, Jaeyoung Chun, Soo Jung Park, Dong-Hoon Yang, Yang Won Min, Bora Keum, Bo-In Lee
Clinical Endoscopy.2017; 50(2): 148. CrossRef
Editorial: Factors Promoting Development of Fibrosis in Crohn’s Disease
Jennifer Bailey
Frontiers in Medicine.2017;[Epub] CrossRef
Circulating cathelicidin levels correlate with mucosal disease activity in ulcerative colitis, risk of intestinal stricture in Crohn’s disease, and clinical prognosis in inflammatory bowel disease
Diana Hoang-Ngoc Tran, Jiani Wang, Christina Ha, Wendy Ho, S. Anjani Mattai, Angelos Oikonomopoulos, Guy Weiss, Precious Lacey, Michelle Cheng, Christine Shieh, Caroline C. Mussatto, Samantha Ho, Daniel Hommes, Hon Wai Koon
BMC Gastroenterology.2017;[Epub] CrossRef
Advanced Oxidation Protein Products Induce Epithelial–Mesenchymal Transition of Intestinal Epithelial Cellsviaa PKC δ-Mediated, Redox-Dependent Signaling Pathway
Xiaoping Xu, Shibo Sun, Fang Xie, Juanjuan Ma, Jing Tang, Shuying He, Lan Bai
Antioxidants & Redox Signaling.2017; 27(1): 37. CrossRef
Incidence of and Risk Factors for Free Bowel Perforation in Patients with Crohn’s Disease
Jong Wook Kim, Ho-Su Lee, Byong Duk Ye, Suk-Kyun Yang, Sung Wook Hwang, Sang Hyoung Park, Dong-Hoon Yang, Kyung-Jo Kim, Jeong-Sik Byeon, Seung-Jae Myung, Yong Sik Yoon, Chang Sik Yu, Jin-Ho Kim
Digestive Diseases and Sciences.2017; 62(6): 1607. CrossRef
Crohn’s disease presenting as gastric outlet obstruction: a therapeutic challenge?
Faisal Inayat, Waqas Ullah, Qulsoom Hussain, Khurram Shafique
BMJ Case Reports.2017; : bcr-2016-218181. CrossRef
Genetic Influences on the Development of Fibrosis in Crohn’s Disease
Bram Verstockt, Isabelle Cleynen
Frontiers in Medicine.2016;[Epub] CrossRef
Crohn's Disease: Specific Concerns in the Elderly
Wei-Chen Lin, Ming-Jen Chen, Cheng-Hsin Chu, Tsang-En Wang, Horng-Yuan Wang, Shou-Chuan Shih, Chen-Wang Chang
International Journal of Gerontology.2016; 10(3): 126. CrossRef
Structural and molecular features of intestinal strictures in rats with Crohn's-like disease
Petra Talapka
World Journal of Gastroenterology.2016; 22(22): 5154. CrossRef
Disease Phenotype, Activity and Clinical Course Prediction Based on C-Reactive Protein Levels at Diagnosis in Patients with Crohn’s Disease: Results from the CONNECT Study
Jee Hye Kwon, Jong Pil Im, Byong Duk Ye, Jae Hee Cheon, Hyun Joo Jang, Kang Moon Lee, You Sun Kim, Sang Wook Kim, Young Ho Kim, Geun Am Song, Dong Soo Han, Won Ho Kim, Joo Sung Kim
Gut and Liver.2016; 10(4): 595. CrossRef
Small Bowel Stricture Mimicking Megacolon in a Patient with Crohn's Disease
Samuel Raimundo Fernandes, Luís Araújo Correia, José Velosa
GE Portuguese Journal of Gastroenterology.2016; 23(6): 319. CrossRef
Factors Associated with Anxiety and Depression in Korean Patients with Inactive Inflammatory Bowel Disease
Min Chul Kim, Yoon Suk Jung, Young Seok Song, Jung In Lee, Jung Ho Park, Chong Il Sohn, Kyu Yong Choi, Dong Il Park
Gut and Liver.2016;[Epub] CrossRef
Disease monitoring in inflammatory bowel disease
Shannon Chang
World Journal of Gastroenterology.2015; 21(40): 11246. CrossRef
Endoskopie in Diagnose, Therapie und Nachsorge
H. Neumann, M. F. Neurath, Raja Atreya
MMW - Fortschritte der Medizin.2015; 157(12): 63. CrossRef
Endoscopic Therapy in Inflammatory Bowel Diseases
Helmut Neumann, Markus F. Neurath, Raja Atreya
Visceral Medicine.2015; 31(4): 280. CrossRef

14,126 View
86 Download
65 Web of Science
70 Crossref

Case Report

Crohn's Disease Complicated with Duodenocolic Fistula: A Case Report: Meng-Tzu Weng, Shu-Chen Wei, Yu-Wen Tien, I-Lun Shih, Jau-Min Wong; Intest Res 2013;11(4):299-302. Published online October 30, 2013; DOI: https://doi.org/10.5217/ir.2013.11.4.299

Abstract PDF

Fistula formation is common during the course of Crohn's disease, whereas duodenocolic fistulas are very rare. The management of internal fistulas in Crohn's disease is a complex issue. Herein, we report a case of duodenocolic fistula manifested by increasing frequency of diarrhea and loss of body weight. The fistula was diagnosed by upper gastrointestinal tract barium series, magnetic resonance enterography, and panendoscopy and was treated with a right hemicolectomy and Whipple procedure because of the simultaneous occurrence of pancreatic head tumor. Subsequent treatment with adalimumab, azathioprine, and mesalazine was prescribed for the maintenance of disease remission, and the patient was well until 18 months after the surgery. (Intest Res 2013;11:299-302)

Citations

Citations to this article as recorded by

Transverse Colonic Stricture Along with Colo-Duodenal Fistula—a Rare and Interesting Finding in Crohn’s Disease
Vivek Agrawal, Raghav Nayar, Md Faizul Haque
Indian Journal of Surgery.2018; 80(5): 527. CrossRef

2,931 View
21 Download
1 Crossref

First
Prev
Page of 1
Next
Last

Search